Trump Team Advances Marijuana Downgrade to Schedule III, Details Unclear
A reported federal move to reclassify medical marijuana is drawing attention as workers and employers watch for immediate impact.
According to the provided report, acting attorney general Todd Blanche signed an order placing FDA-approved and state-licensed medical marijuana into Schedule III, a less restrictive category under federal drug law.
That shift would mark a significant departure from marijuana’s long-standing placement in Schedule I, where it has been classified alongside substances considered to have no accepted medical use.
The complication is that no widely confirmed announcement from the Department of Justice or Drug Enforcement Administration has surfaced, raising questions about whether the change is finalized, partially implemented, or still under review.
“This would represent one of the most significant federal cannabis policy changes in decades,” the report states.
Subscribe free for daily political analysis they won’t broadcast. Join 110K+ readers →
If enacted, the change could reshape how working Americans navigate drug policies. Employees in states where medical marijuana is legal may face fewer conflicts with federal classification, especially in industries that rely on background checks or compliance standards tied to federal law.
At the same time, employers would still retain authority over workplace drug policies, meaning protections for workers could vary widely by company, state, and industry.
What happens next will likely depend on formal rule-making steps, agency guidance, and potential legal challenges that clarify how broadly the reclassification applies.
For now, the reported shift signals a possible turning point, but key details remain unresolved.
Download a FREE Pocket Constitution NOW →
